Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation

References

• Briceno J, Ciria R, De La Mata M, et al. Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. Transplantation. 2010;90(5):530–539.
   PubMed Web of Science ®Google Scholar
• Palmiero HO, Kajikawa P, Boin IF, et al. Liver recipient survival rate before and after model for end-stage liver disease implementation and use of donor risk index. Transplant Proc. 2010;42(10):4113–4115.
   PubMed Web of Science ®Google Scholar
• Silberhumer GR, Pokorny H, Hetz H, et al. Combination of extended donor criteria and changes in the model for end-stage liver disease score predict patient survival and primary dysfunction in liver transplantation: a retrospective analysis. Transplantation. 2007;83(5):588–592.
   PubMed Web of Science ®Google Scholar
• Schemmer P, Nickkholgh A, Hinz U, et al. Extended donor criteria have no negative impact on early outcome after liver transplantation: a single-center multivariate analysis. Transplant Proc. 2007;39(2):529–534.
   PubMed Web of Science ®Google Scholar
• Afonso RC, Hidalgo R, Paes AT, et al. Impact of cumulative risk factors for expanded criteria donors on early survival after liver transplantation. Transplant Proc. 2008;40(3):800–801.
   PubMed Web of Science ®Google Scholar
• Avolio AW, Frongillo F, Nicolotti N, et al. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27. Transplant Proc. 2009;41(1):208–212.
   PubMed Web of Science ®Google Scholar
• Deroose JP, Kazemier G, Zondervan P, et al. Hepatic steatosis is not always a contraindication for cadaveric liver transplantation. HPB (Oxford). 2011;13(6):417–425.
   PubMed Web of Science ®Google Scholar
• Nickkholgh A, Weitz J, Encke J, et al. Utilization of extended donor criteria in liver transplantation: a comprehensive review of the literature. Nephrol Dial Transplant. 2007;22 Suppl 8:viii29–viii36.
   PubMedGoogle Scholar
• De Graaf EL, Kench J, Dilworth P, et al. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the donor risk index. J Gastroenterol Hepatol. 2012;27(3):540–546.
   PubMed Web of Science ®Google Scholar
• Noujaim HM, De Ville De Goyet J, Montero EF, et al. Expanding postmortem donor pool using steatotic liver grafts: a new look. Transplantation. 2009;87(6):919–925.
   PubMed Web of Science ®Google Scholar
• Briceno J, Ciria R, Pleguezuelo M, et al. Impact of donor graft steatosis on overall outcome and viral recurrence after liver transplantation for hepatitis C virus cirrhosis. Liver Transpl. 2009;15(1):37–48 .
   PubMed Web of Science ®Google Scholar
• Doyle MB, Vachharajani N, Wellen JR, et al. Short- and long-term outcomes after steatotic liver transplantation. Arch Surg. 2010;145(7):653–660.
   PubMedGoogle Scholar
• Gao F, Xu X, Ling Q, et al. Efficacy and safety of moderately steatotic donor liver in transplantation. Hepatobiliary Pancreat Dis Int. 2009;8(1):29–33.
   PubMed Web of Science ®Google Scholar
• Chavin KD, Taber DJ, Norcross M, et al. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013;27(5):732–741.
   PubMed Web of Science ®Google Scholar
• McCormack L, Petrowsky H, Jochum W, et al. Use of severely steatotic grafts in liver transplantation: a matched case-control study. Ann Surg. 2007;246(6):940–946. discussion 946-948
   PubMed Web of Science ®Google Scholar
• Dutkowski P, Schlegel A, Slankamenac K, et al. The use of fatty liver grafts in modern allocation systems: risk assessment by the balance of risk (BAR) score. Ann Surg. 2012;256(5):861–868. discussion 868-869
   PubMed Web of Science ®Google Scholar
• Croome KP, Wall W, Quan D, et al. Evaluation of the updated definition of early allograft dysfunction in donation after brain death and donation after cardiac death liver allografts. Hepatobiliary Pancreat Dis Int. 2012;11(4):372–376.
   PubMed Web of Science ®Google Scholar
• Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16(8):943–949.
   PubMed Web of Science ®Google Scholar
• Nemes B, Gelley F, Zadori G, et al. Outcome of liver transplantation based on donor graft quality and recipient status. Transplant Proc. 2010;42(6):2327–2330.
   PubMed Web of Science ®Google Scholar
• Routh D, Sharma S, Naidu CS, et al. Comparison of outcomes in ideal donor and extended criteria donor in deceased donor liver transplant: a prospective study. Int J Surg. 2014;12(8):774–777.
   PubMed Web of Science ®Google Scholar
• Suarez F, Otero A, Solla M, et al. Biliary complications after liver transplantation from maastricht category-2 non-heart-beating donors. Transplantation. 2008;85(1):9–14.
   PubMed Web of Science ®Google Scholar
• Leithead JA, Tariciotti L, Gunson B, et al. Donation after cardiac death liver transplant recipients have an increased frequency of acute kidney injury. Am J Transplant. 2012;12(4):965–975.
   PubMed Web of Science ®Google Scholar
• Nemes B, Gaman G, Doros A. Biliary complications after liver transplantation. Expert Rev Gastroenterol Hepatol. 2015;9(4):447–466.
   PubMed Web of Science ®Google Scholar
• Bacchella T, Galvao FH, Jesus De Almeida JL, et al. Marginal grafts increase early mortality in liver transplantation. Sao Paulo Med J. 2008;126(3):161–165.
   PubMed Web of Science ®Google Scholar
• Gruttadauria S, Vizzini G, Biondo D, et al. Critical use of extended criteria donor liver grafts in adult-to-adult whole liver transplantation: a single-center experience. Liver Transpl. 2008;14(2):220–227.
   PubMed Web of Science ®Google Scholar
• Le Dinh H, De Roover A, Kaba A, et al. Donation after cardio-circulatory death liver transplantation. World J Gastroenterol. 2012;18(33):4491–4506.
   PubMed Web of Science ®Google Scholar
• Cescon M, Zanello M, Grazi GL, et al. Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation. Transplantation. 2011;92(4):439–445.
   PubMed Web of Science ®Google Scholar
• Petridis I, Gruttadauria S, Nadalin S, et al. Liver transplantation using donors older than 80 years: a single-center experience. Transplant Proc. 2008;40(6):1976–1978.
   PubMed Web of Science ®Google Scholar
• Campsen J, Russ P, Kam I. Direct anastomosis of the donor hepatic artery to the supraceliac aorta without extension graft during adult liver transplant in the era of extended criteria donors: report of a case. Case Rep Med. 2010;2010:584631.
   PubMedGoogle Scholar
• Vagefi PA, Parekh J, Ascher NL, et al. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg. 2011;146(9):1052–1059.
   PubMedGoogle Scholar
• Mallik M, Callaghan CJ, Hope M, et al. Comparison of liver transplantation outcomes from adult split liver and circulatory death donors. Br J Surg. 2012;99(6):839–847.
   PubMed Web of Science ®Google Scholar
• Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry. J Hepatol. 2011;55(4):808–813.
   PubMed Web of Science ®Google Scholar
• Jay CL, Luksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg. 2011;253(2):259–264.
   PubMed Web of Science ®Google Scholar
• Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009;146(4):543–552. discussion 552-543
   PubMed Web of Science ®Google Scholar
• Yamamoto S, Wilczek HE, Duraj FF, et al. Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center. Am J Transplant. 2010;10(3):602–611.
   PubMed Web of Science ®Google Scholar
• Abou Abbass A, Abouljoud M, Yoshida A, et al. Biliary complications after orthotopic liver transplantation from donors after cardiac death: broad spectrum of disease. Transplant Proc. 2010;42(9):3392–3398.
   PubMed Web of Science ®Google Scholar
• Foley DP, Fernandez LA, Leverson G, et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg. 2011;253(4):817–825.
   PubMed Web of Science ®Google Scholar
• De Oliveira ML, Jassem W, Valente R, et al. Biliary complications after liver transplantation using grafts from donors after cardiac death: results from a matched control study in a single large volume center. Ann Surg. 2011;254(5):716–722. discussion 722-713
   PubMed Web of Science ®Google Scholar
• Wigmore SJ. Current challenges in liver transplantation following donation after cardiac death. Transplantation. 2010;90(10):1048–1049.
   PubMed Web of Science ®Google Scholar
• Lopez-Andujar R, Montala EM, Vergara FA. Reply to letter: “A question seeking for an answer: use of t-tube in the era of liver transplantation with grafts from extended criteria donors and donors after cardiac death”. Ann Surg. 2015;261(6):174–175.
   PubMed Web of Science ®Google Scholar
• Moris D, Sotiropoulos GC, Vernadakis S. A question seeking for an answer: use of t-tube in the era of liver transplantation with grafts from extended criteria donors and donors after cardiac death. Ann Surg. 2015;261(6):173–174.
   PubMed Web of Science ®Google Scholar
• Lopez-Andujar R, Oron EM, Carregnato AF, et al. T-tube or no T-tube in cadaveric orthotopic liver transplantation: the eternal dilemma: results of a prospective and randomized clinical trial. Ann Surg. 2013;258(1):21–29.
   PubMed Web of Science ®Google Scholar
• Chan EY, Olson LC, Kisthard JA, et al. Ischemic cholangiopathy following liver transplantation from donation after cardiac death donors. Liver Transpl. 2008;14(5):604–610.
   PubMed Web of Science ®Google Scholar
• Baccarani U, Isola M, Adani GL, et al. Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. Clin Transplant. 2010;24(5):631–635.
   PubMed Web of Science ®Google Scholar
• Fondevilla C, Hessheimer AJ, Flores E, et al. Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant. 2012;12(1):162–170.
   PubMed Web of Science ®Google Scholar
• Monbaliu D, Pirenne J, Talbot D. Liver transplantation using Donation after cardiac death donors. J Hepatol. 2012;56(2):474–485.
   PubMed Web of Science ®Google Scholar
• Subramanian V, Seetharam AB, Vachharajani N, et al. Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation. 2011;92(11):1259–1268.
   PubMed Web of Science ®Google Scholar
• Yagci G, Fernandez LA, Knechtle SJ, et al. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C. Transplant Proc. 2008;40(1):219–223.
   PubMed Web of Science ®Google Scholar
• Hernandez-Alejandro R, Croome KP, Quan D, et al. Increased risk of severe recurrence of hepatitis C virus in liver transplant recipients of donation after cardiac death allografts. Transplantation. 2011;92(6):686–689.
   PubMed Web of Science ®Google Scholar
• Taner CB, Bulatao IG, Keaveny AP, et al. Use of liver grafts from donation after cardiac death donors for recipients with hepatitis C virus. Liver Transpl. 2011;17(6):641–649.
   PubMed Web of Science ®Google Scholar
• Uemura T, Ramprasad V, Hollenbeak CS, et al. Liver transplantation for hepatitis C from donation after cardiac death donors: an analysis of OPTN/UNOS data. Am J Transplant. 2012;12(4):984–991.
   PubMed Web of Science ®Google Scholar
• Tao R, Ruppert K, Cruz RJ Jr., et al. Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts. Liver Transpl. 2010;16(11):1288–1295.
   PubMed Web of Science ®Google Scholar
• Northup PG, Argo CK, Nguyen DT, et al. Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US national transplant registry analysis. Transpl Int. 2010;23(10):1038–1044.
   PubMed Web of Science ®Google Scholar
• Ballarin R, Cucchetti A, Spaggiari M, et al. Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. Transplantation. 2011;91(11):1265–1272.
   PubMed Web of Science ®Google Scholar
• Burra AT, Li Y, Tseng JF, et al. Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg. 2011;35(7):1590–1595.
   PubMed Web of Science ®Google Scholar
• O’Leary JG, Neri MA, Trotter JF, et al. Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined. Transpl Int. 2012;25(8):825–829.
   PubMed Web of Science ®Google Scholar
• Yu L, Koepsell T, Manhart L, et al. Survival after orthotopic liver transplantation: the impact of antibody against hepatitis B core antigen in the donor. Liver Transpl. 2009;15(10):1343–1350.
   PubMed Web of Science ®Google Scholar
• MacConmara MP, Vachharajani N, Wellen JR, et al. Utilization of hepatitis B core antibody-positive donor liver grafts. HPB (Oxford). 2012;14(1):42–48.
   PubMed Web of Science ®Google Scholar
• Angelico M, Nardi A, Marianelli T, et al. Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: evidence from the liver match cohort study. J Hepatol. 2013;58(4):715–723.
   PubMed Web of Science ®Google Scholar
• Lucidi V, Lemye AC, Baire L, et al. Use of marginal donors for liver transplantation: a single-center experience within the Eurotransplant patient-driven allocation system. Transplant Proc. 2007;39(8):2668–2671.
   PubMed Web of Science ®Google Scholar
• Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet. 2006;367(9506):225–232.
   PubMed Web of Science ®Google Scholar
• Mathur AK, Heimbach J, Steffick DE, et al. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10(11):2512–2519.
   PubMed Web of Science ®Google Scholar
• Nafidi O, Marleau D, Roy A, et al. Identification of new donor variables associated with graft survival in a single-center liver transplant cohort. Liver Transpl. 2010;16(12):1393–1399.
   PubMed Web of Science ®Google Scholar
• Serrano MT, Garcia-Gil A, Arenas J, et al. Outcome of liver transplantation using donors older than 60 years of age. Clin Transplant. 2010;24(4):543–549.
   PubMed Web of Science ®Google Scholar
• Kim DY, Moon J, Island ER, et al. Liver transplantation using elderly donors: a risk factor analysis. Clin Transplant. 2011;25(2):270–276.
   PubMed Web of Science ®Google Scholar
• Ghinolfi D, Marti J, De Simone P, et al. Use of octogenarian donors for liver transplantation: a survival analysis. Am J Transplant. 2014;14(9):2062–2071.
   PubMed Web of Science ®Google Scholar
• Hoyer DP, Paul A, Saner F, et al. Safely expanding the donor pool: brain dead donors with history of temporary cardiac arrest. Liver Int. 2015;35(6):1756–1763.
   PubMed Web of Science ®Google Scholar
• Briceno J, Ciria R, Pleguezuelo M, et al. Contribution of marginal donors to liver transplantation for hepatitis C virus infection. Transplant Proc. 2007;39(7):2297–2299.
   PubMed Web of Science ®Google Scholar
• Yilmaz N, Shiffman ML. Impact of the donor liver with steatosis in patients with hepatitis C virus: not so FAst. Liver Transpl. 2009;15(1):4–6.
   PubMed Web of Science ®Google Scholar
• Uemura T, Nikkel LE, Hollenbeak CS, et al. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C? Transpl Int. 2012;25(6):671–679.
   PubMed Web of Science ®Google Scholar
• Balfoussia D, Yerrakalva D, Hamaoui K, et al Advances in machine perfusion graft viability assessment in kidney, liver, pancreas, lung, and heart transplant. Exp Clin Transplant. 2012;10(2):87–100.
   PubMed Web of Science ®Google Scholar
• Wali M, Harrison RF, Gow PJ, et al. Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C. Gut. 2002;51(2):248–252.
   PubMed Web of Science ®Google Scholar
• Botha JF, Thompson E, Gilroy R, et al. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation. Liver Int. 2007;27(6):758–763.
   PubMed Web of Science ®Google Scholar
• Thiagarajan P, Ryder SD. The hepatitis C revolution part 1: antiviral treatment options. Curr Opin Infect Dis. 2015;28(6):563–571.
   PubMed Web of Science ®Google Scholar
• Lee S-G. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant. 2015;15(1):17–38.
   PubMed Web of Science ®Google Scholar
• Hackl C, Schlitt HJ, Melter M, et al. Current developments in pediatric liver transplantation. World J Hepatol. 2015;7(11):1509–1520.
   PubMedGoogle Scholar
• Mittler J, Pascher A, Neuhaus P, et al. The utility of extended criteria donor organs in severely ill liver transplant recipients. Transplantation. 2008;86(7):895–896.
   PubMed Web of Science ®Google Scholar
• Gordon Burroughs S, Busuttil RW. Optimal utilization of extended hepatic grafts. Surg Today. 2009;39(9):746–751.
   PubMed Web of Science ®Google Scholar
• Harring TR, Nguyen NT, Cotton RT, et al. Liver transplantation with donation after cardiac death donors: a comprehensive update. J Surg Res. 2012;178(1):502–511.
   PubMed Web of Science ®Google Scholar
• Blok JJ, Braat AE, Adam R, et al. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl. 2012;18(1):112–119.
   PubMed Web of Science ®Google Scholar
• Barshes NR, Horwitz IB, Franzini L, et al. Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers. Am J Transplant. 2007;7(5):1265–1270.
   PubMed Web of Science ®Google Scholar
• Abt PL, Desai NM, Crawford MD, et al. Survival following liver transplantation from non-heart-beating donors. Ann Surg. 2004;239(1):87–92.
   PubMed Web of Science ®Google Scholar
• Nguyen JH, Bonatti H, Dickson RC, et al. Long-term outcomes of donation after cardiac death liver allografts from a single center. Clin Transplant. 2009;23(2):168–173.
   PubMed Web of Science ®Google Scholar
• Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6(4):783–790.
   PubMed Web of Science ®Google Scholar
• Briceno J, Ciria R, De La Mata M, et al. Extended criteria donors in liver transplant candidates with hepatorenal syndrome. Clin Transplant. 2011;25(3):E257–263.
   Google Scholar
• Lee W-C, Chan K-M, Chou H-S, et al. Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era. Ann Surg. 2013;258(2):306–311.
   PubMed Web of Science ®Google Scholar
• Cauley RP, Vakili K, Fullington N, et al. Deceased-donor split-liver transplantation in adult recipients: is the learning curve over? J Am Coll Surg. 2013;217(4):672–684.e671.
   PubMed Web of Science ®Google Scholar
• Berenguer M. Risk of extended criteria donors in hepatitis C virus-positive recipients. Liver Transpl. 2008;14 Suppl 2:S45–50.
   Google Scholar
• Lake JR, Shorr JS, Steffen BJ, et al. Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant. 2005;5(3):549–557.
   PubMed Web of Science ®Google Scholar
• Ghabril M, Dickson RC, Krishna M, et al. Liver transplantation using young pediatric donor grafts in adults with hepatitis C infection. Transplantation. 2009;87(8):1174–1179.
   PubMed Web of Science ®Google Scholar
• Burra P, Loreno M, Russo FP, et al. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients. Liver Transpl. 2009;15(6):619–628.
   PubMed Web of Science ®Google Scholar
• Baltz AC, Trotter JF. Living donor liver transplantation and hepatitis C. Clin Liver Dis. 2003;7(3):651–665, viii.
   PubMedGoogle Scholar
• Dall’Agata M, Gramenzi A, Biselli M, et al. Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents? World J Gastroenterol. 2014;20(28):9253–9260.
   PubMed Web of Science ®Google Scholar
• Pungpapong S, Aqel BA, Koning L, et al. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013;19,:690–700.
   PubMed Web of Science ®Google Scholar
• Coilly A, Dumortier J, Botta-Fridlund D, et al. Multicenter experience with boceprevir or telaprevir to treat Hepatitis C recurrence after liver transplantation: when present becomes past, what lessons for future? PLoS ONE. 2015;10(9):e0138091. doi:10.1371/journal.pone.0138091.
   Google Scholar
• Charlton M, Gane E, Manns MP, et al. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis c virus infection after liver transplantation. Gastroenterology. 2015;148:108–117.
   PubMed Web of Science ®Google Scholar
• Seifert LL, Vorona E, Bester C, et al. Interferon-free sofosbuvir-based Anti-HCV therapy after liver transplantation. Ann Transplant. 2015;20:561–568.
   PubMed Web of Science ®Google Scholar
• Gastaca M. Extended criteria donors in liver transplantation: adapting donor quality and recipient. Transplant Proc. 2009;41(3):975–979.
   PubMed Web of Science ®Google Scholar
• Angele MK, Rentsch M, Hartl WH, et al. Effect of graft steatosis on liver function and organ survival after liver transplantation. Am J Surg. 2008;195(2):214–220.
   PubMed Web of Science ®Google Scholar
• Northup PG, Pruett TL, Kashmer DM, et al. Donor factors predicting recipient survival after liver retransplantation: the retransplant donor risk index. Am J Transplant. 2007;7(8):1984–1988.
   PubMed Web of Science ®Google Scholar
• Marti J, Fuster J, Navasa M, et al. Effects of graft quality on non-urgent liver retransplantation survival: should we avoid high-risk donors? World J Surg. 2012;36(12):2914–2922.
   PubMed Web of Science ®Google Scholar
• Monbaliu D, Liu Q, Libbrecht L, et al. Preserving the morphology and evaluating the quality of liver grafts by hypothermic machine perfusion: a proof-of-concept study using discarded human livers. Liver Transpl. 2012;18(12):1495–1507.
   PubMed Web of Science ®Google Scholar
• Kim JS, Broering DC, Tustas RY, et al. Split liver transplantation: past, present and future. Pediatr Transplant. 2004;8(6):644–648.
   PubMed Web of Science ®Google Scholar
• Broering DC, Mueller L, Ganschow R, et al. Is there still a need for living-related liver transplantation in children? Ann Surg. 2001;234(6):713–721. discussion 721-712
   PubMed Web of Science ®Google Scholar
• Decoster EL, Troisi R, Sainz-Barriga M, et al. Improved results for adult split liver transplantation with extended right lobe grafts: could we enhance its application? Transplant Proc. 2009;41(8):3403–3406.
   PubMed Web of Science ®Google Scholar
• Maggi U, DeFeo TM, Andorno E, et al. Fifteen years and 382 extended right grafts from in situ split livers in a multicenter study: are these still extended criteria liver grafts? Liver Transpl. 2015;21(4):500–511.
   PubMed Web of Science ®Google Scholar
• Jay CL, Skaro AI, Ladner DP, et al. Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl. 2012;18(6):630–640.
   PubMed Web of Science ®Google Scholar
• Wan P, Li Q, Zhang J, et al. Right lobe split liver transplantation versus whole liver transplantation in adult recipients: A systematic review and meta-analysis. Liver Transpl. 2015;21(7):928–943.
   PubMed Web of Science ®Google Scholar
• Zambelli M, Andorno E, De Carlis L, et al. Full-right-full-left split liver transplantation: the retrospective analysis of an early multicenter experience including graft sharing. Am J Transplant. 2012;12(8):2198–2210.
   PubMed Web of Science ®Google Scholar
• Aseni P, De Feo TM, De Carlis L, et al. A prospective policy development to increase split-liver transplantation for 2 adult recipients: results of a 12-year multicenter collaborative study. Ann Surg. 2014;259(1):157–165.
   PubMed Web of Science ®Google Scholar
• Obara H, Matsuno N, Shigeta T, et al. Temperature controlled machine perfusion system for liver. Transplant Proc. 2013;45(5):1690–1692.
   PubMed Web of Science ®Google Scholar
• Dutkowski P, Schlegel A, De Oliveira M, et al. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol. 2014;60(4):765–772.
   PubMed Web of Science ®Google Scholar
• Bessems M, Doorschodt BM, Kolkert JL, et al. Preservation of steatotic livers: a comparison between cold storage and machine perfusion preservation. Liver Transpl. 2007;13(4):497–504.
   PubMed Web of Science ®Google Scholar
• Franchello A, Gilbo N, David E, et al. Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). Am J Transplant. 2009;9(7):1629–1639.
   PubMed Web of Science ®Google Scholar
• Olschewski P, Gass P, Ariyakhagorn V, et al. The influence of storage temperature during machine perfusion on preservation quality of marginal donor livers. Cryobiology. 2010;60(3):337–343.
   PubMed Web of Science ®Google Scholar
• Schmeding M, Rademacher S, Boas-Knoop S, et al. rHuEPo reduces ischemia-reperfusion injury and improves survival after transplantation of fatty livers in rats. Transplantation. 2010;89(2):161–168.
   PubMed Web of Science ®Google Scholar
• Mangus RS, Fridell JA, Vianna RM, et al. Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in extended criteria liver donors. Liver Transpl. 2008;14(3):365–373.
   PubMed Web of Science ®Google Scholar
• Bae C, Henry SD, Guarrera JV. Is extracorporeal hypothermic machine perfusion of the liver better than the ‘good old icebox’? Curr Opin Organ Transplant. 2012;17(2):137–142.
   PubMed Web of Science ®Google Scholar
• Dutkowski P, De Rougemont O, Clavien P-A. Machine perfusion for ‘marginal’ liver grafts. Am J Transplant. 2008;8(5):917–924.
   PubMed Web of Science ®Google Scholar
• Schlegel A, Kron P, Graf R, et al. Hypothermic Oxygenated Perfusion (HOPE) downregulates the immune response in a rat model of liver transplantation. Ann Surg. 2014;260(5):931–937. discussion 937-938
   PubMed Web of Science ®Google Scholar
• Vekemans K, Liu Q, Pirenne J, et al. Artificial circulation of the liver: machine perfusion as a preservation method in liver transplantation. Anat Rec (Hoboken). 2008;291(6):735–740.
   PubMedGoogle Scholar
• De Rougemont O, Breitenstein S, Leskosek B, et al. One hour hypothermic oxygenated perfusion (HOPE) protects nonviable liver allografts donated after cardiac death. Ann Surg. 2009;250(5):674–683.
   PubMed Web of Science ®Google Scholar
• Stegemann J, Hirner A, Rauen U, et al. Use of a new modified HTK solution for machine preservation of marginal liver grafts. J Surg Res. 2010;160(1):155–162.
   PubMed Web of Science ®Google Scholar
• Vogel T, Brockmann JG, Friend PJ. Ex-vivo normothermic liver perfusion: an update. Curr Opin Organ Transplant. 2010;15(2):167–172.
   PubMed Web of Science ®Google Scholar
• Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010;10(2):372–381.
   PubMed Web of Science ®Google Scholar
• Tulipan JE, Stone J, Samstein B, et al. Molecular expression of acute phase mediators is attenuated by machine preservation in human liver transplantation: preliminary analysis of effluent, serum, and liver biopsies. Surgery. 2011;150(2):352–360.
   PubMed Web of Science ®Google Scholar
• Guarrera JV. Assist devices: machine preservation of extended criteria donors. Liver Transpl. 2012;18 Suppl 2:S31–33.
   Google Scholar
• Flisiak R. Role of Ito cells in the liver function. Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists. 1997;48(3):139–145.
   PubMedGoogle Scholar
• Lambrecht J, Mannaerts I, Van Grunsven LA. The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis. Front Physiol. 2015;6:209.
   PubMed Web of Science ®Google Scholar
• Florimond A, Chouteau P, Bruscella P, et al., et al. Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication. Gut. 2015;64(6):957–965.
   PubMed Web of Science ®Google Scholar
• Gouw AS, Clouston AD, Theise ND. Ductular reactions in human liver: diversity at the interface. Hepatology. 2011;54(5):1853–1863.
   PubMed Web of Science ®Google Scholar
• Prakoso E, Tirnitz-Parker JE, Clouston AD, et al. Analysis of the intrahepatic ductular reaction and progenitor cell responses in hepatitis C virus recurrence after liver transplantation. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2014;20(12):1508–1519.
   PubMed Web of Science ®Google Scholar
• Hong JC, Yersiz H, Kositamongkol P, et al. Liver transplantation using organ donation after cardiac death: a clinical predictive index for graft failure-free survival. Arch Surg. 2011;146(9):1017–1023.
   PubMedGoogle Scholar
• Selck FW, Grossman EB, Ratner LE, et al. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008;248(4):599–607.
   PubMed Web of Science ®Google Scholar
• Bruzzone P, Giannarelli D, Adam R. A preliminary European Liver and Intestine Transplant Association-European Liver Transplant Registry study on informed recipient consent and extended criteria liver donation. Transplant Proc. 2013;45(7):2613–2615.
   PubMed Web of Science ®Google Scholar
• Nemeth N, Kiss F, Hever T, et al. Hemorheological consequences of hind limb ischemia-reperfusion differs in normal and gonadectomized male and female rats. Clin Hemorheol Microcirc. 2012;50(3):197–211.
   PubMed Web of Science ®Google Scholar
• Nemeth N, Furka I, Miko I. Hemorheological changes in ischemia-reperfusion: an overview on our experimental surgical data. Clin Hemorheol Microcirc. 2014;57(3):215–225.
   PubMed Web of Science ®Google Scholar